Chinese Medical Association   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Beijing China (1915)

Organization Overview

First Clinical Trial
2010
NCT01159847
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Chinese Medical Association | Chinese Medical Association--Sarcoma group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 4)

Delirium (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 2)

Diabetes Mellitus, Type 2 (Phase 4)

Glucose Intolerance (Phase 4)

Neoplasm Metastasis (Phase 3)

Obesity (Phase 4)

Osteosarcoma (Phase 3)

Prediabetic State (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 20